Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A
lock (
) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Your browser is not supported
Switch to Chrome, Edge, Firefox or Safari
This Advisory highlights the importance of methadone as a tool for treating incarcerated with people with opioid use disorder (OUD). The Advisory describes different institutional arrangements for providing methadone in correctional settings.
This report provides important insights into the effectiveness of high-dose buprenorphine for treating opioid use disorder, especially among individuals exposed to high-potency synthetic opioids.
Medications for Opioid Use Disorder: An Effective Treatment for Justice-Involved Persons Reentering the Community Brief Reference Document explores how Opioid Use Disorder (OUD) treatment for justice-involved individuals will help lower the overdose risk for people reentering the community. It discusses treatment barriers, strategies to address them, and key reentry services to promote the successful reintegration of people returning to the community from incarceration.
Innovative and Holistic Programs that Offer Medications for Opioid Use Disorder to Pregnant and Parenting Women Issue Brief highlights two SAMHSA-funded grant programs—E-MOMS and KS HEART—to illustrate the implementation of critical service elements for women’s Substance Use Disorder/Opioid Use Disorder (SUD/OUD) treatment in two states.
The Guidelines address the implementation of medications for opioid use disorder (MOUD) in state prisons and practical information about medications, service delivery models, regulatory requirements, staff training, and cultural issues that may affect the uptake and integration of MOUD.
